Michael Straza, MD, PhD

Publications

• Mesenchymal-Type Genetic Mutations Are Likely Prerequisite for Glioblastoma Multiforme to Metastasize Outside the Central Nervous System: An Original Case Series and Systematic Review of the Literature.

  (Laurin BJ, Treffy R, Connelly JM, Straza M, Mueller WM, Krucoff MO.) World Neurosurg. 2024 Nov 02 PMID: 39419169 SCOPUS ID: 2-s2.0-85208505671 10/18/2024

• Changes in Daily Apparent Diffusion Coefficient on Fully Quantitative Magnetic Resonance Imaging Correlate With Established Genomic Pathways of Radiation Sensitivity and Reveal Novel Biologic Associations.

  (Hall WA, Mathison AJ, DeVoe E, Tschannen M, Wendt-Andrae J, Straza M, Awan M, Puckett LL, Lawton CAF, Schultz C, Urrutia R, Kerns S, Torres-Roca JF, Li XA, Erickson B, Nevalainen MT, Zimmermann MT, Paulson E.) Int J Radiat Oncol Biol Phys. 2024 Oct 01;120(2):570-578 PMID: 38819340 SCOPUS ID: 2-s2.0-85194948255 05/31/2024

• Cystic Brain Metastasis Outcomes After Gamma Knife Radiation Therapy

  (Amidon RF, Livingston K, Kleefisch CJ, Martens M, Straza M, Puckett L, Schultz CJ, Mueller WM, Connelly JM, Noid G, Morris K, Bovi JA.) Advances in Radiation Oncology. January 2024;9(1) SCOPUS ID: 2-s2.0-85167453267 01/01/2024

• Symptomatic radionecrosis after postoperative but not preoperative stereotactic radiosurgery in a single patient: illustrative case.

  (Laurin BJ, Straza M, Noid G, Connelly JM, Mueller WM, Bovi J, Krucoff MO.) J Neurosurg Case Lessons. 2023 Oct 16;6(16) PMID: 37870754 PMCID: PMC10584084 SCOPUS ID: 2-s2.0-85174582314 10/23/2023

• Outcomes of Tolerability, Acute Toxicity and Quality of Life from MR-Guided Radiation Therapy (1.5T MR-Linac) for Liver Metastases in the MOMENTUM Study.

  (Westley R, Peltenburg J, Aitken KL, Awan MJ, Braam PM, Daamen LA, Hosni A, Intven MPW, Janssen T, Schytte T, Sonke JJ, Straza MW Jr, Paulson ES, Hall WA, Nowee ME.) Int J Radiat Oncol Biol Phys. 2023 Oct 01;117(2S):e156 PMID: 37784746 10/03/2023

• Quality of Life in Prostate Cancer Patients Undergoing Daily Adaptive Versus Non-Adaptive Radiation Therapy Utilizing A 1.5 Tesla MR-Linac.

  (Ponce SEB, Daamen LA, Van der Voort vanZyp J, Westerhoff JM, Pos FJ, Christodouleas JP, Choudhury A, van der Heide U, Lawton CAF, Straza MW Jr, Bedi M, Paulson ES, Nasief HG, Li A, Verkooijen H, Tree A, Hall WA.) Int J Radiat Oncol Biol Phys. 2023 Oct 01;117(2S):S114-S115 PMID: 37784299 10/03/2023

• Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology.

  (Conger RL, Mora J, Straza MW, Erickson BA, Lawton CAF, Schultz CJ, Currey A, Bedi M, Siker ML, Hall WA.) Adv Radiat Oncol. 2023;8(4):101206 PMID: 37152489 PMCID: PMC10157111 05/08/2023

• Case report: Two unique cases of co-existing primary brain tumors of glial origin in opposite hemispheres.

  (Singhal I, Coss D, Mueller W, Straza M, Krucoff MO, Santos-Pinheiro F.) Front Oncol. 2022;12:1018840 PMID: 36568179 PMCID: PMC9771729 SCOPUS ID: 2-s2.0-85144424557 12/27/2022

• Case report: Fractional brain tumor burden magnetic resonance mapping to assess response to pulsed low-dose-rate radiotherapy in newly-diagnosed glioblastoma.

  (Amidon RF, Santos-Pinheiro F, Straza M, Prah MA, Mueller WM, Krucoff MO, Connelly JM, Kleefisch CJ, Coss DJ, Cochran EJ, Bovi JA, Schultz CJ, Schmainda KM.) Front Oncol. 2022;12:1066191 PMID: 36561526 PMCID: PMC9763264 SCOPUS ID: 2-s2.0-85144231369 12/24/2022

• Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology.

  (Conger R, Mora J, Straza MW Jr, Erickson BA, Lawton CAF, Schultz CJ, Currey AD, Bedi M, Saeed H, Tsai S, Siker ML, Hall WA.) Int J Radiat Oncol Biol Phys. 2021 Nov 01;111(3S):e105 PMID: 34700688 SCOPUS ID: 2-s2.0-85120931396 10/28/2021

• Quantification and Dosimetric Impact of Normal Organ Motion During Adaptive Radiation Therapy Plan Verification Using a 1.5 Tesla Magnetic Resonance Equipped Linear Accelerator (MR LINAC).

  (Wittman D, Paulson ES, Eastwood D, Banerjee A, Banla LI, Schultz CJ, Awan MJ, Chen X, Omari E, Straza MW Jr, Li A, Erickson BA, Hall WA.) Int J Radiat Oncol Biol Phys. 2021 Nov 01;111(3S):S48-S49 PMID: 34700566 SCOPUS ID: 2-s2.0-85120924793 10/28/2021

• Characterization of Underrepresented Populations in Modern Era Clinical Trials Involving Radiation Therapy.

  (Bero EH, Rein LE, Banerjee A, Straza MW, Lawton CAF, Schultz CJ, Erickson BA, Siker ML, Hall WA.) Pract Radiat Oncol. 2021;11(6):453-459 PMID: 34742459 SCOPUS ID: 2-s2.0-85118502646 11/08/2021